Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.335 CAD | 0.00% | -4.29% | -14.10% |
Mar. 27 | Transcript : Microbix Biosystems Inc. - Shareholder/Analyst Call | |
Mar. 14 | Microbix Says Clot-Buster Drug Project Advancing | MT |
Sales 2024 * | 18.59M 25.47M | Sales 2025 * | 21.32M 29.21M | Capitalization | 33.55M 45.96M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.8 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.57 x |
P/E ratio 2024 * |
16.8
x | P/E ratio 2025 * |
16.8
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.65% |
Latest transcript on Microbix Biosystems Inc.
1 week | -4.29% | ||
Current month | -8.22% | ||
1 month | -9.46% | ||
3 months | -18.29% | ||
6 months | +15.52% | ||
Current year | -14.10% |
Managers | Title | Age | Since |
---|---|---|---|
Cameron Groome
CEO | Chief Executive Officer | - | 12-03-07 |
James Currie
DFI | Director of Finance/CFO | - | 16-10-31 |
Mark Luscher
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Cochran
BRD | Director/Board Member | - | 90-09-30 |
Peter Blecher
BRD | Director/Board Member | - | 05-12-05 |
Cameron Groome
CEO | Chief Executive Officer | - | 12-03-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.335 | 0.00% | 21,500 |
24-04-23 | 0.335 | -1.47% | 44,286 |
24-04-22 | 0.34 | 0.00% | 41,786 |
24-04-19 | 0.34 | -4.23% | 68,486 |
24-04-18 | 0.355 | +1.43% | 5,500 |
Delayed Quote Toronto S.E., April 24, 2024 at 03:58 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.10% | 33.67M | |
+4.09% | 43.43B | |
+47.81% | 41.69B | |
+9.45% | 41.31B | |
-10.92% | 27.14B | |
+9.32% | 25.28B | |
-24.87% | 18.47B | |
+29.70% | 12.59B | |
+1.28% | 12.33B | |
+7.78% | 11.03B |
- Stock Market
- Equities
- MBX Stock